Longduoduo Co Ltd Revenue Growth Rates (LDDD), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Longduoduo Co Ltd  (OTC: LDDD)
 

LDDD's Revenue Growth by Quarter and Year

Longduoduo Co Ltd's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

LDDD Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter June 0.63
3rd Quarter March 0.19
2nd Quarter December 0.35
1st Quarter September 0.66
FY 1.83

LDDDs Annual Revenue
Longduoduo Co Ltd's Revenue in the fiscal year 2026 $ 1.82 millions
Longduoduo Co Ltd's Revenue in the fiscal year 2025 $ 4.26 millions
Longduoduo Co Ltd's Revenue in the fiscal year 2024 $ 7.39 millions
Longduoduo Co Ltd's Revenue in the fiscal year 2023 $ 3.82 millions
Longduoduo Co Ltd's Revenue in the fiscal year 2022 $ 0.41 millions




LDDD Revenue fourth quarter 2026 Y/Y Growth Comment
Longduoduo Co Ltd reported fall in Revenue in the fourth quarter 2026 by -32.87% to $ 0.63 millions, from the same quarter in 2025.
The drop in the fourth quarter 2026 Longduoduo Co Ltd's Revenue compares unfavorably to the Company's average Revenue doubling of 250.54%.

According to the results reported in the fourth quarter 2026, Longduoduo Co Ltd achieved the best Revenue growth in Medical Equipment & Supplies industry. While Longduoduo Co Ltd' s Revenue drop of -32.87% ranks overall at the positon no. 0 in the fourth quarter 2026.


LDDD Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter June -32.87 % -43.71 % -45.42 % 264.29 %
3rd Quarter March -75.64 % -56.42 % 539.29 % -61.11 %
2nd Quarter December -80.34 % -23.93 % 3800 % -93.55 %
1st Quarter September -14.29 % -51.57 % 278.57 % -44 %
FY   -57.12 % -42.22 % 93.46 % -

Financial Statements
Longduoduo Co Ltd's fourth quarter 2026 Revenue $ 0.63 millions LDDD's Income Statement
Longduoduo Co Ltd's fourth quarter 2025 Revenue $ 0.94 millions Quarterly LDDD's Income Statement


LDDD Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter June 232.12 % 20.51 % -6.7 % 992.86 %
3rd Quarter March -45.71 % -56.18 % -23.5 % 366.67 %
2nd Quarter December -46.97 % 131.17 % 47.17 % -85.71 %
1st Quarter September -29.79 % -53.89 % -48.04 % -50 %
FY (Year on Year)   -57.12 % -42.22 % 93.46 % -


Back to LDDD Growth rate Comparisons >> Back to LDDD Growth rate Comparisons >>


Revenue fourth quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #0

Revenue Y/Y Growth Statistics
High Average Low
3545.64 % 250.54 % -93.06 %
 
Revenue fourth quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #0
Revenue Y/Y Growth Statistics
High Average Low
3545.64 % 250.54 % -93.06 %
 

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Longduoduo Co Ltd's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
992 % 70.23 % -84.55 %
(Jun 30 2023)  


LDDD's IV. Quarter Q/Q Revenue Comment
Longduoduo Co Ltd achieved in the IV. Quarter 2026 above company average sequential Revenue doubling of 232.12%, to $ 0.63 millions, from $0.19 millions in the third quarter.
LDDD is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Medical Equipment & Supplies industry Longduoduo Co Ltd achieved highest sequential Revenue growth. While Longduoduo Co Ltd's Revenue growth quarter on quarter, overall rank is 0.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #0
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #0
Revenue Q/Q Growth Statistics
High Average Low
992 % 70.23 % -84.55 %
(Jun 30 2023)  


LDDD's IV. Quarter Q/Q Revenue Comment
Longduoduo Co Ltd achieved in the IV. Quarter 2026 above company average sequential Revenue doubling of 232.12%, to $ 0.63 millions, from $0.19 millions in the third quarter.
LDDD is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Medical Equipment & Supplies industry Longduoduo Co Ltd achieved highest sequential Revenue growth. While Longduoduo Co Ltd's Revenue growth quarter on quarter, overall rank is 0.


Longduoduo Co Ltd's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 1.82 $ 2.13 $ 2.72 $ 4.15 $ 4.26
Y / Y Revenue Growth (TTM) -57.24 % -57.31 % -54.68 % -36.81 % -42.32 %
Year on Year Revenue Growth Overall Ranking # 3691 # 4343 # 3674 # 3726 # 3784
Seqeuential Revenue Change (TTM) -14.51 % -21.68 % -34.44 % -2.59 % -14.65 %
Seq. Revenue Growth (TTM) Overall Ranking # 3691 # 4343 # 3674 # 3726 # 3784


Cumulative Revenue growth Comment
Longduoduo Co Ltd showed decline, but improvement compare to trailing twelve month Revenue decrease in Mar 31 2026. If the fiscal year would end in Jun 30 2026, Longduoduo Co Ltd's annual Revenue fall would be -57.24% year on year to $2 millions.

Longduoduo Co Ltd achieved highest trailing twelve month year on year Revenue growth. While Total ranking has impoved so far to 3691, from total ranking in previous quarter at 4343.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall # 0

Revenue TTM Y/Y Growth Statistics
High Average Low
450.15 %
 47.14 %
-57.31 %
(Mar 31 2024)  


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 # 0
Cumulative Revenue growth Comment
Longduoduo Co Ltd showed decline, but improvement compare to trailing twelve month Revenue decrease in Mar 31 2026. If the fiscal year would end in Jun 30 2026, Longduoduo Co Ltd's annual Revenue drop would be -57.24% year on year to $2 millions.

Longduoduo Co Ltd achieved highest trailing twelve month year on year Revenue growth. While Total ranking has impoved so far to 3691, from total ranking in previous quarter at 4343.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall # 0

Revenue TTM Y/Y Growth Statistics
High Average Low
450.15 %
47.14 %
-57.31 %
(Mar 31 2024)  






Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
LDDD's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue drop for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Bio rad Laboratories Inc -0.05%$ -0.046 millions
Seer Inc -0.29%$ -0.289 millions
Dyadic International Inc -0.57%$ -0.568 millions
Teva Pharmaceutical Industries Limited-0.81%$ -0.814 millions
Aytu Biopharma Inc-0.91%$ -0.911 millions
Neuropace Inc -1.32%$ -1.323 millions
Ardent Health Inc -1.40%$ -1.400 millions
Sunshine Biopharma Inc -1.56%$ -1.557 millions
Pacific Biosciences Of California Inc -1.71%$ -1.706 millions
United Therapeutics Corporation-1.92%$ -1.916 millions
Orasure Technologies Inc-1.93%$ -1.930 millions
Pulmonx Corporation-1.93%$ -1.931 millions
Volitionrx Limited-1.97%$ -1.975 millions
Organon and Co -2.26%$ -2.258 millions
Airsculpt Technologies Inc -2.53%$ -2.527 millions
Charles River Laboratories International inc -2.72%$ -2.718 millions
Perrigo Company Plc-3.17%$ -3.171 millions
Zai Lab Limited-3.33%$ -3.333 millions
Vanda Pharmaceuticals Inc -3.92%$ -3.919 millions
Teladoc Health Inc -3.95%$ -3.952 millions
Dentsply Sirona Inc -4.06%$ -4.060 millions
Sanuwave Health Inc -4.18%$ -4.181 millions
Treace Medical Concepts Inc -4.24%$ -4.244 millions
Fortrea Holdings Inc -4.52%$ -4.519 millions
Positron Corporation-6.91%$ -6.907 millions
Standard Biotools Inc -7.05%$ -7.046 millions
Inspire Medical Systems inc -7.32%$ -7.316 millions
Adapthealth Corp -7.50%$ -7.505 millions
China Pharma Holdings Inc-7.55%$ -7.548 millions
Skinhealth Systems Inc -7.68%$ -7.680 millions


About Longduoduo Co Ltd Revenue Growth Rates (LDDD), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Longduoduo Co Ltd (CIK 1892316).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001213900-26-105343
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Longduoduo Co Ltd’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.